FDA declines to approve Proteus-Otsuka sensor-equipped pill, asks for more tests

The FDA declined to approve what would have been the first mass market drug to incorporate Proteus Digital Health's ingestible sensor. The drug, a collaboration between Proteus and Otsuka Pharmaceuticals, combines the Proteus system with the antipsychotic pharmaceutical Abilify.
Source: mobihealthnews - Category: Information Technology Source Type: news